Moderna Presents Promising Early Data for Its Investigational Cancer Antigen Therapy at the ...

RNA-4359 has advanced into the Phase 2 portion of the ongoing Phase 1/2 trial CAMBRIDGE, MA / ACCESS Newswire / October 12, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that clinical, safety and ...
The Business Times

Asean is already economically divided. AI will make it worse

Stories of reinvention, potential retrenchment are becoming common as companies and industries embrace the AI tidal wave Read ...